22nd Century (XXII) About to Experience a Growth Spurt with New Initiatives on the Horizon XXII transacts an immediately accretive deal in the cannabi...
Hot Sector and Opportunity in a Psychedelic Biopharma Enterprise with a Focus Toward New Science, Shareholder Value and Recently Announced Plans to Up-list to the NASDAQ
Under the radar, low float with patented psilocybin treatments. Silo Pharma (OTCQB: SILO) heads are turning with names like Pfizer (PFE), Eli Lilly (L...
Today CTXR released a business update including highlights and upcoming milestones. The company has clarified the status of its lead product Mino-Lok.
News out this morning. The company has clarified the status of its lead product Mino-Lok. Is the Market Value of Citius Pharma (CTXR) About to Make a ...
Updated coverage on one of our favorite NASDAQ stocks coming tomorrow at the bell
Good day everyone, The stock market indices are giving investors a reason to be optimistic and to invest. The NASDAQ, DJIA and the S&P 500 are hit...
BioSig (BSGM) and Its NeuroClear Subsidiary Are Leading the Way in Bioelectric Medicine with Amazing Potential
BioSig (BSGM) and Its NeuroClear Subsidiary Are Leading the Way in Bioelectric Medicine with Amazing Potential Good day everyone, We are updating our ...
New disruptive technology report coming tomorrow at market open. Details and recent report updates.
The “New Normal” is Developing and There is a New Disruptive Technology on the Horizon New report coming tomorrow, Wednesday June 30th, 2021 at market...
JanOne (NASDAQ: JAN) is Trending as Its Lead Product for Pain Advances in Clinical Trials
Following today’s volume and price action, could JAN have a short position that exceeds the 2.38M shares in the float? One Redditor thinks so...
Citius Pharma (CTXR) Prepares for Phase III Data Release at the End of This Month and the Potential Catalysts are Lining Up.
(NASDAQ: CTXR) is now up well over 200% since our December report. Citius Pharma (CTXR) Prepares for Phase III Data Release at the End of This Month a...
Do you Consider ESG Criteria Before you Invest in a Company? New Report will be Released Tomorrow on One of our Favorite NASDAQ Stocks
Good day everyone and welcome to all our new members, We continue to scour the markets for companies that present with the opportunity for near-term g...
Jupiter Wellness (JUPW) has an Accretive Acquisition in Process, is Generating Revenue and Conducting Clinicals for CBD Medicine
Jupiter Wellness (JUPW) has an Accretive Acquisition in Process, is Generating Revenue and Conducting Clinicals for CBD Medicine Good day everyone, We...
